Maryn McKenna

Journalist and Author

  • Contact
  • Blog
  • Speaking and Teaching
  • Audio & Video
    • Audio
    • Video
  • Journalism
    • Articles
    • Past Newspaper Work
  • Books
    • Big Chicken
    • SuperBug
    • Beating Back the Devil
  • Bio
  • Home

African Scientist: African Corruption Made Ebola Worse

November 4, 2014 By Maryn Leave a Comment

Daliborlev (CC), FLickr

Daliborlev (CC), Flickr

Since last week, there has been some good news on the Ebola front: a suggestion that the epidemic in Liberia is beginning to slow down, with fewer new cases reported. At the same time, there is a new outbreak in Sierra Leone, in a part of the country that thought it had beaten the disease and then self-quarantined to keep it at bay. So it is probably too soon to hope that the entire international outbreak is on its way to being extinguished.

At the same time, two major international medical meetings happening this week have allowed researchers to discuss the newest reports from  the field — but not with equal success. The annual meeting of the American Society of Tropical Medicine and Hygiene, the largest medical society devoted to diseases such as Ebola, lost a significant number of attendees when the conference’s host state, Louisiana, threatened to forcibly quarantine anyone traveling from a country experiencing Ebola, whether or not that person had been exposed. Meanwhile, Vienna, Austria had no such qualms, and so the International Meeting on Emerging Diseases and Surveillance proceeded without any difficulties, allowing physicians and epidemiologists fresh from the Ebola zone to share reports.

It’s from that second meeting that this week’s news comes. Oyewale Tomori, president of the Nigerian Academy of Science and a leader of the World Health Organization’s Ebola response in 1995, used the IMED podium to deliver a stinging critique of the behavior of African governments during the current crisis, charging that internal corruption has crippled the continent’s ability to fight its own disease battles.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: Ebola, Nigeria

The Grim Future if Ebola Goes Global

October 27, 2014 By Maryn Leave a Comment

Healthcare workers load a man suspected of suffering from the Ebola virus onto an ambulance in Kenema, Sierra Leone, on Sept. 25, 2014.

Healthcare workers load a man suspected of suffering from the Ebola virus onto an ambulance in Kenema, Sierra Leone, on Sept. 25, 2014. Tanya Bindra/AP

If you listened hard over the weekend to the chatter around the political theater of detaining a nurse returning from the Ebola zone in a tent with no heat or running water, you might have heard a larger concern expressed. It was this: What happens if this kind of punitive detention — which went far beyond what medical authorities recommend — deters aid workers from going to West Africa to help?

As a reminder, the African Ebola epidemic is still roaring in three countries; two others have contained the disease, but it has now leaked to a sixth, Mali. The case count is 10,141, with 4,922 deaths. Last month, the Centers for Disease Control and Prevention estimated that if the epidemic continued on its current course, cases would hit 1.4 million by next January. Last week, Yale researchers said in the journal Lancet Infectious Diseases that even current promises of international aid will not contain the epidemic — so the volunteering of medical personnel such as that nurse becomes even more important.

But what if, because of this weekend’s events, volunteers are discouraged from going to West Africa, for fear of how they will be received on return? Or what if they do go, and their efforts are still not enough?

I wanted to be sure I wasn’t over-imagining what might happen next with Ebola, if it is not contained at its source now. For a fact-check, I turned to Jody Lanard and Peter Sandman, two risk-communication experts who have been involved in most of the big epidemic threats of the past decades. (I met them, I think, in the first run-up of concern over H5N1 avian flu in 2003.)

I hoped they would tell me not to be too worried about Ebola becoming a permanent threat in West Africa. Instead, they told me to be very worried indeed.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: Ebola

Ebolanoia: The Only Thing We Have to Fear is Ebola Fear Itself

October 22, 2014 By Maryn Leave a Comment

panic

Star5112 / Flickr

It is almost a month now since Thomas Eric Duncan appeared at the emergency room of Texas Health Presbyterian Hospital, was sent home after evaluation, and returned two days later with symptoms of Ebola. On Monday, his family and the health workers who treated him at the hospital were released from quarantine, with none having fallen ill.

But if you’ve been paying any attention to the Ebola news, you’ll know that the story is far from over, with one nurse who took care of him in Dallas now hospitalized at NIH (and upgraded to good condition Tuesday) and the other at Emory University, where the aid workers who fell ill in Africa also received treatment and recovered. Duncan remains the only person who came to the US with Ebola but not already identified and under medical care.

Given our nationwide reaction, though, you might think we have had as many cases as West Africa.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: Ebola

What Would Keep Ebola from Spreading in the US? Investing in Simple Research Years Ago.

October 13, 2014 By Maryn Leave a Comment

Daliborlev (CC), FLickr

Daliborlev (CC), Flickr

There’s a thing you learn, when you’ve been writing about infectious diseases for a while: People love drama. They’re not so much with detail.

Drama is H5N1 avian flu killing half the people who contract it, and the enormous surge in whooping cough, and the sinister movement of almost-untreatable NDM-1 resistance from South Asia to the West.

Detail is the question of whether health care workers treating pandemic-flu patients should expect viral spread for 3 feet or 6 feet; and why immunity conferred by the current pertussis vaccine fades a few years earlier than expected; and how hospitals can encourage their janitors to clean rooms more thoroughly, when they’ve always treated them as a disposable part of the staff.

All of those details are crucial to controlling those diseases. All of them are also research questions. None of them, guaranteed, have gotten the attention or funding that would answer the questions in a way that equips us to counter the dramatic problems.
[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: CDC, Ebola, infection control

US Will Screen Air Passengers for Signs of Ebola. Will It Work?

October 9, 2014 By Maryn Leave a Comment

Masked customs officers look on in a screening area for international passengers from United flight 998 from Brussels at Newark airport in Newark, N.J., Saturday, Oct. 4, 2014. New Jersey health officials say Ebola has been ruled out as the cause of illness for a man who became sick on a flight from Brussels to the United States.

Masked customs officers look on in a screening area for international passengers from United flight 998 from Brussels at Newark airport in Newark, N.J., Saturday, Oct. 4, 2014. New Jersey health officials say Ebola has been ruled out as the cause of illness for a man who became sick on a flight from Brussels to the United States. Viorel Florescu / AP Photo / Northjersey.com

If you’ve been following the Ebola story, you may have noticed that the Centers for Disease Control and Prevention announced a move yesterday to try to keep the disease off US soil. At the five US airports that receive most passengers from the three countries where Ebola is circulating, passengers will be singled out on the basis of their travel records; interviewed by means of a questionnaire; and have their temperature taken, to see if they have a fever.

It’s the first attempt to control Ebola at the US border, announced, probably coincidentally, on the same day as the death of the only Ebola patient to make it into the US thus far. Political pressure for the CDC to do something was growing, and some visible step was necessary. But in the public health world, I am hearing some doubt whether it will work. Here are some reasons why.
[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: Airport, CDC, Ebola, screening

Keys to Controlling Ebola in the US: Travel Records and Infection Control

October 1, 2014 By Maryn Leave a Comment

Daliborlev (CC), FLickr

Daliborlev (CC), Flickr

If you’re at all interested in infectious diseases, you’ve probably heard by now that a person traveled to the United States while infected with Ebola, was diagnosed and is now in a hospital in Texas. (I was on a flight without Wi-Fi yesterday from before the press conference was announced to after it concluded. Turning my phone on after arrival was… interesting.)

The Centers for Disease Control and Prevention held a press conference yesterday afternoon (transcript is here), and WIRED’s Greg Miller covered it.

The quick details:

  • The infected person flew from Liberia to the US on Sept. 19-20 to visit family members who live in Texas.*
  • He began to develop symptoms on Sept. 24 (important because victims are infectious only after symptoms develop).
  • He went to an ER in Dallas on Sept. 26 and was given antibiotics and sent home.
  • Two days later, Sept. 28, he was taken by ambulance to Texas Presbyterian Hospital in Dallas and was admitted on suspicion of Ebola and put in isolation.
  • The test results confirming the diagnosis came down yesterday, the same day as the announcement.

 

(*A quick Google will demonstrate that the patient and his family have been named by the Associated Press, with the New York Times using the name and attributing it to AP. Given the unnecessary panic around Ebola at this point, I have conflicting thoughts about whether and how the name should be used, so am passing on using it for now.)

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: CDC, Ebola, infection control

White House Actions on Antibiotic Resistance: Big Steps, Plus Disappointments

September 22, 2014 By Maryn Leave a Comment

Roman Boed (CC), Flickr

Roman Boed (CC), Flickr

The United States government proposed several important steps last week that, if accomplished, will significantly change how this country attempts to counter the advance of antibiotic resistance, bringing us within reach of the more complete programs which exist in Europe. But as significant as it is, the new program has some perplexing gaps that left experts attending to the issue disappointed.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: agriculture, animals, antibiotics, Resistance, White House

Via Farmworkers, Superbugs Find a Route Away from Drug-Using Farms

September 21, 2014 By Maryn Leave a Comment

Pig farms from the air. Image: Maryn McKenna

Pig farms from the air. Image: Maryn McKenna

One of the persistent questions regarding antibiotic use in meat production, and its effect on the health of humans who live far away from production farms, is: How do the resistant bacteria that result get from one place to another? That is: Most people accept by now that using antibiotics in livestock-raising causes drug resistance to emerge in the systems of those animals, in their guts or on their skin. But whether those newly resistant bacteria leave the farm, and how they make the trip, is both fought over and—despite much investigation—still under-researched.

Some studies have shown that bacteria can move off farms in groundwater, on the feet of flies, and via dust on the wind. What is insufficiently explored—because it is difficult to get large meat-production facilities to cooperate—is whether farm workers themselves are serving as a transport vehicle.

A new study just published (and open-access, so anyone can read it) helps to answer that question. It looks at the possibility that workers on large hog farms are carrying away drug-resistant staph or MRSA, and especially a type of resistant staph — known familiarly as “pig MRSA” and more technically as “livestock-associated MRSA” — that emerged on hog farms a decade ago and is directly linked to farm-drug use.

(If you’ve been visiting Superbug the blog for a while, you might remember pig MRSA; the story of its discovery in a Dutch farmer’s daughter 10 years ago also was told for the first time in Superbug the book. If it’s a new concept to you, you might be interested in this archive here.)

The new study finds that hog farmers are carrying multi-drug resistant livestock-associated MRSA away from the farm and — this is the crucial bit — that their bodies are hanging onto those bacteria, in a way that might allow them to spread, for up to 14 days.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: MRSA, North Carolina, ST398

The Mathematics of Ebola Trigger Stark Warnings: Act Now or Regret It

September 14, 2014 By Maryn Leave a Comment

Daliborlev (CC), FLickr

Daliborlev (CC), Flickr

The Ebola epidemic in Africa has continued to expand since I last wrote about it, and as of a week ago, has accounted for more than 4,200 cases and 2,200 deaths in five countries: Guinea, Liberia, Nigeria, Senegal and Sierra Leone. That is extraordinary: Since the virus was discovered, no Ebola outbreak’s toll has risen above several hundred cases. This now truly is a type of epidemic that the world has never seen before. In light of that, several articles were published recently that are very worth reading.

The most arresting is a piece published last week in the journal Eurosurveillance, which is the peer-reviewed publication of the European Centre for Disease Prevention and Control (the EU’s Stockholm-based version of the US CDC). The piece is an attempt to assess mathematically how the epidemic is growing, by using case reports to determine the “reproductive number.” (Note for non-epidemiology geeks: The basic reproductive number — usually shorted to R0 or “R-nought” — expresses how many cases of disease are likely to be caused by any one infected person. An R0 of less than 1 means an outbreak will die out; an R0 of more than 1 means an outbreak can be expected to increase. If you saw the movie Contagion, this is what Kate Winslet stood up and wrote on a whiteboard early in the film.)

The Eurosurveillance paper, by two researchers from the University of Tokyo and Arizona State University, attempts to derive what the reproductive rate has been in Guinea, Liberia and Sierra Leone. (Note for actual epidemiology geeks: The calculation is for the effective reproductive number, pegged to a point in time, hence actually Rt.) They come up with an R of at least 1, and in some cases 2; that is, at certain points, sick persons have caused disease in two others.

You can see how that could quickly get out of hand, and in fact, that is what the researchers predict. Here is their stop-you-in-your-tracks assessment:

In a worst-case hypothetical scenario, should the outbreak continue with recent trends, the case burden could gain an additional 77,181 to 277,124 cases by the end of 2014.

That is a jaw-dropping number.
[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: CDC, Ebola, ECDC

Unseen Suburban Danger: Children Dying of Mosquito-Borne Diseases

September 10, 2014 By Maryn Leave a Comment

James Jordan (CC), Flickr

James Jordan (CC), Flickr

Every once in a while a scientific paper pops up in my stream that makes me think, not Cool, or Ick, but: Wow, I had no idea. I’ve just read one, published last month in Pediatrics, which definitely falls into the last category. My extreme abbreviation of the findings: On average, more than 100 children and teens each year are made dangerously ill or paralyzed by infections carried by mosquitoes, and two die.

I think of mosquito-borne infections in the United States — that is, primarily West Nile virus, and the much less well-known La Crosse virus and Eastern equine encephalitis virus — as a problem of adults. I had no clue they were so dangerous to children. (And if I didn’t, most of you probably didn’t either.)

Here’s a more detailed breakdown.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: CDC, Eee, mosquitoes

Chicken Company Perdue Takes Big Steps to Reduce Antibiotic Use

September 3, 2014 By Maryn Leave a Comment

Karen Jackson (CC), Flickr

Karen Jackson (CC), Flickr

Big news in the world of food policy, farming and antibiotic use: Perdue Farms, the third-largest chicken producer in the United States, announced today that during the past decade it has ceased using most of the antibiotics that formerly propped up its chicken production.

There are caveats to that “most,” and I’ll explain them. But it’s important to say up front that this is a nationally significant move and looks like an industry-leading step.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: antibiotics, chicken, food policy, food safety, poultry, Resistance

CDC Director on Ebola: 'The Window of Opportunity Really Is Closing'

September 2, 2014 By Maryn Leave a Comment

Daliborlev (CC), FLickr

Daliborlev (CC), Flickr

I said last month that I was going to try to stay out of Ebola news because so much is being written about it elsewhere. Since then, the African outbreak — now really an epidemic, since it is in multiple countries —  has ballooned to 3,000 cases, and the World Health Organization has predicted it may take 6 months or more to bring it under control.

Something caught my attention today though that felt worth highlighting. Dr. Tom Frieden, director of the US Centers for Disease Control and Prevention, gave a lengthy press conference immediately after returning to the US from a visit to the Ebola zone. Frieden has shown in the past that he knows how to be outspoken in a very strategic way; yet even so, the urgency of his language, and his call for an immediate, comprehensive global response, was striking.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: Africa, CDC, Ebola

How Agriculture's Growth Promoters Might Work: A Mouse Study Sheds Some Light

August 19, 2014 By Maryn Leave a Comment

Rama (CC), FLickr

Rama (CC), Flickr

The farm practice that underlies most agricultural use of antibiotics is known as “growth promotion”: It calls for giving very small doses of antibiotics routinely to meat animals because those doses cause them to gain fat and muscle more quickly than they would otherwise. Growth promotion dates back to the early days of the antibiotic era, and has always been somewhat mysterious. Though there were attempts to pick apart its mechanisms in the 1950s and 1960s (I’ve been reading some fascinating old accounts), for the most part, people simply accepted that it worked. It’s only in the past decade or so, as interest has increased in the microbes that reside everywhere in our and animals’ bodies (a vast community generally known as the microbiome), that researchers have begun trying to dissect what is going on.

The scientific team that has probably pursued this most intensely is the NYU Langone Medical Center lab led by Martin J. Blaser. Blaser published a popular account of their research into antibiotics’ effect on obesity, asthma, diabetes, and other disorders in Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues, published in April. (Disclosure: I reviewed the book for Nature.) Two years ago, the team showed that giving small doses of antibiotics to very young mice affected genes controlling metabolism of nutrients, and caused the mice to gain weight. Now they have followed up that research with detailed work exploring how much the timing and length of antibiotics affects weight gain. Though the work is still in mice, it leads to provocative conclusions about how growth promoters work in livestock, and what early-life antibiotics might do to humans as well.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: antibiotics, growth promoters, microbiome, Resistance

Ebola in Africa and the U.S.: A Curation

August 4, 2014 By Maryn Leave a Comment

Daliborlev (CC), FLickr

Daliborlev (CC), Flickr

I’ve stayed out of the Ebola news so far, for a couple of reasons. First, as longtime readers know, I’m writing a book; I’m in the last 6 months of it and the work is intense and involves a lot of travel. I’m not always available at the exact moment news breaks. Second, I try to explore things here that readers may not have heard about elsewhere. The Ebola outbreak has been building in West Africa for a while, but when it was revealed at the end of last week that two American aid workers had caught the disease — and that they were being transported back to the US for treatment — the news and the reaction to it instantly filled every channel. Over the weekend, so much misinformation and outrage got pumped out that it feels as though there’s no way to cut through the noise.

But I have a few thoughts. Start with this: No, I don’t think the two aid workers who are being returned to the US pose any risk at all to the average American, or even the average Atlanta resident. Here’s my marker on that: I’m an Atlanta resident. I live less than 2 miles from the CDC and Emory University (the aid workers are being treated in a special unit housed at Emory on behalf of the CDC; the two institutions are next door to each other). My entire neighborhood and a good part of my various friendship circles are CDC employees, Emory healthcare workers, or both.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: CDC, Ebola

Resistant 'Nightmare Bacteria' Increase Fivefold in Southeastern U.S.

July 26, 2014 By Maryn Leave a Comment

Klebsiella, Janice Carr, CDC

Klebsiella, Janice Carr, CDC

There’s worrisome news here in the southeastern U.S., buried in a journal that is favorite reading only for superbug geeks like me. The rate at which hospitals are recognizing cases of CRE — the form of antibiotic resistance that is so serious the CDC dubbed it a “nightmare” — rose five times over between 2008 and 2012.

Within that bad news, there are two especially troubling points. First, the hospitals where this resistance factor was identified were what is called “community” hospitals, that is, not academic referral centers. That’s an important distinction, because academic medical centers tend to be where the most cutting-edge care is performed, and where the sickest people are. As a result, they are where last-resort antibiotics are used the most, and therefore where resistance is most likely to emerge. That CRE was found so widely not in academic centers, but rather in community hospitals, is a signal that it is probably moving through what medicine calls “the community,” which is to say, anywhere outside healthcare. Or, you know, everyday life.

A second concern is that the authors of the study, which is in Infection Control and Hospital Epidemiology, assume that their finding is an underestimate of the actual problem.
[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: CDC, CRE, Klebsiella

Update on the Found Vials: There Weren't 6; There Were 327. (Not All of Them Were Smallpox)

July 16, 2014 By Maryn Leave a Comment

Variola, CDC

Variola, CDC

I was away reporting most of today, and while I was out, a few federal emails landed in my mail with what probably sounded like a  thud. One was an official announcement from the Food and Drug Administration; the others were copies of FDA and NIH emails that people there thought I should see.

They all said the same thing: The six vials of smallpox virus found in an FDA cold-storage room on the National Institutes of Health campus July 1 and announced by the CDC last week had company. A lot of company: 321 other vials. Some of them contained other “select agents,” infectious pathogens considered serious enough — for the illness they create, or the lack of a vaccine to prevent or drugs to treat them — to be considered potential bioterror agents.

(If you’ve missed this story so far, catch up here, here, here and here.)

Here’s the gist of the FDA’s external announcement:

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: CDC, FDA, NIH, smallpox

CDC Lab Errors and Their Implications: Congressional Hearing Today

July 16, 2014 By Maryn Leave a Comment

TEM image of influenza A H7N9, CDC

TEM image of influenza A H7N9, CDC

Leadership of the Centers for Disease Control and Prevention will appear today before the Energy and Commerce Committee of the House of Representatives, to answer questions about the lab accidents with flu and anthrax that the CDC disclosed in its press conference last week.

On deck: CDC Director Dr. Thomas Frieden; Dr. Joseph Henderson, Deputy Director of the CDC’s Office of Security and Emergency Preparedness; staff from the Government Accountability Office and the Animal and Plant Health Inspection Services of USDA; and academic experts.

Tuesday night, the witnesses’ written testimony was placed on the Committee’s webpage. Frieden’s says in part:

First, these incidents should never have happened, and the lack of adequate procedures and oversight that allowed them to happen was totally unacceptable. Although it does not appear that these incidents resulted in any illness, and there was no release of pathogens as a result of either event, this does not excuse what happened.

Second, we will take every step possible to prevent any future incident that could put our laboratory scientists, others in the CDC workforce and the broader community, or the public at risk… I am personally overseeing a series of reforms designed to address these specific incidents – but more broadly, recognizing that our challenge is larger than addressing these two specific incidents, I will oversee the careful and deliberate review of existing, and development of new safety practices at all levels of our Agency…

Third, we will explore the broader implications of these incidents and incorporate the lessons learned from them to proactively prevent future incidents at laboratories across the Nation that work with pathogens.

The two accidents, and especially the flu accident — in which a serious strain of avian flu was mistakenly sent to a poultry-research lab, instead of a mild one — have revived concerns about research currently being pursued, not at the CDC, that soups up flu strains to artificial combinations of transmissibility and virulence. The fear, which I’ve written about here and here, is that a lab accident could allow such manmade flu strains to escape.

In advance of the hearing, a group of scientists who have been critical of the lab-enhanced flu work (generally called “gain of function” or “dual use” research) have banded together as the Cambridge Working Group to put their concerns on the record. [Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: anthrax, CDC, congress, influenza

The Leader of the Smallpox Eradication Effort Speaks About the Virus' Rediscovery

July 14, 2014 By Maryn Leave a Comment

Variola, CDC

Variola, CDC

Those of us who write about infectious diseases faced a conundrum last week, when the news broke that 60-year-old vials containing viable smallpox virus had been found on the National Institutes of Health campus. A responsible reporter always wants to talk to the experts in any subject. But when it comes to smallpox, experts can be hard to find.

Smallpox was one of the world’s worst killers, from prehistory through the first half of the 20th century. Yet there has not been a case of the dreadful disease anywhere since 1978, so few physicians working today have seen one. The virus is supposed to exist in only two highly secure stockpiles, so few scientists do research on it. And the aggressive campaign that chased the disease from the globe — the only human infection for which that claim can be made — ended 34 years ago. Many of the men and women who led it are in retirement, and a number have died.

Fortunately, the physician who headed that international campaign — 85-year-old Donald Ainslie Henderson, universally known as D.A. — is still working in public health, as a distinguished scholar at the bioterrorism-focused Center for Health Security of the University of Pittsburgh Medical Center. Henderson literally wrote the book on smallpox — twice, in fact: He co-authored the World Health Organization’s definitive 1,500-page reference, Smallpox and its Eradication (known in public health as the Red Book), and in 2009 wrote a personal reminiscence of the global battle, Smallpox: The Death of a Disease. Just last month, he published a lengthy, closely argued essay in the journal he co-edits, Biosecurity and Bioterrorism, urging the WHO to finally consent to destroying the last stocks of smallpox virus. (A decision the international agency declined to take; instead, for the sixth time in a row, it postponed a vote on destruction in favor of more study.) There are only a few people working in public health — not just in the United States, but in the world — who possess equivalent knowledge of smallpox, its eradication, and the persistent fears afterward that it could be used as a bioterror agent.

Last week, I talked to Henderson about the live-virus discovery and whether it will affect calls for all stocks of smallpox to be destroyed. He had some surprising things to say, particularly about the availability of smallpox vaccine. I edited our conversation for clarity and length.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: CDC, FDA, NIH, smallpox

Virus in Found Tubes of Smallpox Is Viable

July 11, 2014 By Maryn Leave a Comment

Variola, CDC

Variola, CDC

Here’s an update on the vials found on the National Institutes of Health campus last week that were labeled smallpox, and transported earlier this week to the Centers for Disease Control and Prevention: The CDC and NIH have both confirmed that the virus in two of the tubes is viable.

That is, if the vials had broken, and someone had come in contact with the dried contents, the result could have been a smallpox infection — something that has not been seen in the world since 1978.

NIH director Dr. Francis Collins made the announcement in an email sent to staff today, which was shared with me. Simultaneously, CDC director Dr. Thomas Frieden announced in a press briefing that the CDC lab studying the vials, which earlier had identified the contents as smallpox virus based on PCR of the contents’ DNA, had induced growth of the contents in a tissue culture, and confirmed that the growing material is smallpox virus.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: CDC, FDA, NIH, smallpox

What the Forthcoming White House Report on Antibiotic Resistance Will Ask For

July 11, 2014 By Maryn Leave a Comment

e-Magine Art (CC), Flickr

e-Magine Art (CC), Flickr

Among the groups that work on awareness of antibiotics resistance — which include major medical and public health organizations as well as nonprofits trying to direct attention to antibiotic misuse in medicine and agriculture — there has been a lot of anticipation of a forthcoming report by the President’s Council of Advisors on Science and Technology. The report, which has been in the works for months, will be published shortly, possibly as early as next week. Today, the council — known as PCAST for short — held a public meeting to discuss the report’s contents and vote as a group to accept or rejected. The meeting was webcast, and as far as I could tell, the vote was unanimous.

Though the report itself won’t be out for a bit, the meeting gave a good sense of what the report will say. For accessibility, PCAST runs live voice-recognition transcription of its meetings; so while the meeting was proceeding, I grabbed a transcript to review later. Here’s what seems to be coming.

[Read more…]

Filed Under: Science, Science Blogs, Superbug Tagged With: agriculture, antibiotics, FDA, Resistance

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 38
  • Next Page »

© [fl_year} Maryn McKenna | Web Design Services by Sumy Designs, LLC

Facebook